GlaxoSmithKline

New practical guide for businesses to measure air pollutant emissions across value chains

The Alliance for Clean Air, launched by the World Economic Forum and the Clean Air Fund, published a practical guide…

1 year ago

Nueva guía práctica para que las empresas midan las emisiones de contaminantes atmosféricos en las cadenas de valor

La Alianza para el Aire Limpio, lanzada por el Foro Económico Mundial y el Fondo de Aire Limpio, publicó una…

1 year ago

GlaxoSmithKline: US FDA regulatory submission acceptance of New Drug Application for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor

(PRESS RELEASE) LONDON, 19-Apr-2022 — /EuropaWire/ — GlaxoSmithKline plc (LON: GSK), a British multinational science-led healthcare company, has announced the…

2 years ago

New Desiccant Products at Medica 2021

(PRESS RELEASE) BUCKINGHAMSHIRE, UK, 26-Oct-2021 — /EuropaWire/ — This year, Baltimore Innovations will be unveiling a new range of Humidity…

3 years ago

Baltimore Innovations at U-Tech 2021

(PRESS RELEASE) BUCKINGHAMSHIRE, UK, 26-Oct-2021 — /EuropaWire/ — Moisture-control experts Baltimore Innovations have just announced their participation at U-Tech 2021…

3 years ago

Unilever to acquire the Health Food Drinks portfolio (GSK HFD) of GlaxoSmithKline (GSK) in Asia

LONDON/ ROTTERDAM, 04-Dec-2018 — /EuropaWire/ — Unilever today announced it has signed an agreement to acquire the Health Food Drinks portfolio…

5 years ago

GlaxoSmithKline to present comprehensive portfolio of respiratory research and scientific innovation at the American Thoracic Society (ATS) conference

Brentford, United Kingdom, 17-May-2018 — /EuropaWire/ — GlaxoSmithKline plc (GSK) will present extensive data from across its respiratory portfolio, pipeline and…

6 years ago

GlaxoSmithKline, Innoviva: Landmark IMPACT study shows significant benefits of Trelegy Ellipta for patients with chronic obstructive pulmonary disease (COPD)

LONDON, 20-Apr-2018 — /EuropaWire/ — Once-daily single inhaler triple therapy superior to Relvar/Breo Ellipta and Anoro Ellipta across multiple endpoints…

6 years ago

Relieve the Stress from Asthma Management with New MyAsthma App

NOTTINGHAM, 18-Apr-2017 — /EuropaWire/ — A new and unique smartphone app to help people with asthma manage their condition has been…

7 years ago

GlaxoSmithKline welcomes Brian McNamara as CEO of GSK’s Consumer Healthcare division

LONDON, 29-Sep-2016 — /EuropaWire/ — GSK today announced that Brian McNamara, is appointed Chief Executive Officer (CEO) of GSK’s Consumer Healthcare…

8 years ago

GlaxoSmithKline completes sale of remaining stake in Aspen Pharmacare Holdings Ltd at ZAR 300 per share

LONDON, 29-Sep-2016 — /EuropaWire/ — Further to the announcement by GlaxoSmithKline on 28 September 2016, GlaxoSmithKline has agreed to the sale…

8 years ago

GlaxoSmithKline intends to sell remaining stake in Aspen Pharmacare Holdings Ltd

LONDON, 29-Sep-2016 — /EuropaWire/ — GlaxoSmithKline announces that it intends to sell its remaining stake in Aspen Pharmacare Holdings Ltd ("Aspen").…

8 years ago

Kuehne + Nagel to run the core business of transporting products from the raw materials supplier to trade customers for GlaxoSmithKline (GSK)

London / UK, Schindellegi / CH, 13-1-2016 — /EuropaWire/ — Kuehne + Nagel and GSK signed an end-to-end global logistics…

8 years ago

Urs Rohner to join GlaxoSmithKline’s Board as Non-Executive Director from 1 January 2015

LONDON, 9-10-2014 — /EuropaWire/ — GlaxoSmithKline plc (LSE: GSK) today announced the appointment of Mr Urs Rohner to its Board…

10 years ago

GlaxoSmithKline and Medicines for Malaria Venture start phase III global programme of tafenoquine for the treatment of Plasmodium vivax malaria

London, 29-4-2014 — /EuropaWire/ — GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) today announced the start of a phase III global…

10 years ago

GlaxoSmithKline’s Incruse® (umeclidinium) gets European Commission marketing authorisation as maintenance bronchodilator treatment of COPD

London, 29-4-2014 — /EuropaWire/ — GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the European Commission has granted marketing authorisation for Incruse® (umeclidinium) as…

10 years ago

GlaxoSmithKline delivers Q3 core EPS of 28.9p (+16% CER) and dividend of 19p (+6%)

London, UK, 23-10-2013 — /EuropaWire/ — GSK announces Q3 core EPS growth of 16% and dividend of 19p Core EPS 28.9p (+16%) benefiting…

11 years ago

GlaxoSmithKline submitted NDA to US FDA for the once daily inhaled corticosteroid (ICS) treatment, fluticasone furoate (FF), administered using the ELLIPTA™ dry powder inhaler

London, UK, 23-10-2013 — /EuropaWire/ — GlaxoSmithKline plc (LSE:GSK) today announced the submission of a New Drug Application (NDA) in the US…

11 years ago

GSK and Pfizer owned ViiV Healthcare announced US regulatory submission for STR combining dolutegravir with abacavir and lamivudine for people living with HIV

London, UK, 23-10-2013 — /EuropaWire/ — ViiV Healthcare today announced the submission of a regulatory application in the United States for its…

11 years ago